Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trialIacopo Olivotto, Amos Katz, Ahmad Masri et al.|The Lancet|2020Cited by 1.2k
Clinical Features and Natural History of PRKAG2 Variant Cardiac GlycogenosisÁngela López‐Sainz, Diego Alonso-García, Fernándo Domínguez et al.|Journal of the American College of Cardiology|2020Cited by 104